Evidence map›Paper›PMID 33691611›Full record

ArticleCancer biology & therapy2021

Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model.

Christopher W Schultz, Gorka Ruiz de Garibay, Anika Langer, Ji-Bin Liu, Teena Dhir, Calum Leitch, Corinne E Wessner, Mireia Mayoral, Bo Zhang, Mihaela Popa and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 3 countries.

Christopher W SchultzDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0001-5731-2847
Gorka Ruiz de GaribayDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Anika LangerDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Ji-Bin LiuDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Teena DhirDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Calum LeitchDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Corinne E WessnerDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Mireia MayoralDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Bo ZhangDepartment of Ultrasound, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Mihaela PopaDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Chunwang HuangDepartment of Echocardiography, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Spiros KotopoulisDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Xianghong LuoShanghai General Hospital, Shanghai, China.
Yanhua ZhenDepartment of Ultrasound, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Sihua NiuDepartment of Ultrasound, Peking University People's Hospital, Beijing, China.
Mehnoosh TorkzabanDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Kirk WallaceGE Global Research, Niskayuna, NY, USA.
John R EisenbreyDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Jonathan R BrodyDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
Emmet McCormackDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Flemming ForsbergDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0003-2215-1371
Thomas Jefferson University · USUniversity of Bergen · NOCentral South University · CNGE Global Research (United States) · USGuangdong Academy of Medical Sciences · CNHaukeland University Hospital · NOPeking University · CNSecond Affiliated Hospital of Zhengzhou University · CNShanghai First People's Hospital · CN

Funding

Optimizing Ultrasound Enhanced Delivery of TherapeuticsR01CA199646 · NCI · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2016 to 2023
$2.9M
Vevo 2100 ultrasound scannerS10OD010408 · OD · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2012 to 2012
$525k
NCI NIH HHS R01 CA199646NIH HHS S10 OD010408
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in the modern world, in part due to poor delivery of chemotherapeutics. Sonoporation can be used to enhance the efficacy of standard of care therapies for PDAC. Using xenograft models of PDAC we investigate sonoporation using four ifferent ultrasound contrast agents (UCAs) and two ultrasound regimens to identify the ideal parameters to increase therapeutic efficacy. MIA-PaCa2 xenografts in over 175 immunodeficient mice were treated with gemcitabine and paclitaxel and subjected to low or high power ultrasound (60 and 200 mW/cm

Indexed as

AdenocarcinomaAnimalsCarcinoma, Pancreatic DuctalCell Line, TumorDisease Models, AnimalHumansMaleMiceMicrobubblesSonicationSurvival Analysisdrug deliverynovel therapeuticPancreatic Ductal Adenocarcinomasonoporationultrasound contrast agent

Identifiers

PMID33691611
PMCPMC8043187
OpenAlexW3134586794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.